F.D.A. Rushed a Drug for Preterm Births. Did It Put Speed Over Science? March 25, 2022 Auto Bot Aduhelm (Drug), Food and Drug Administration, Regulation and Deregulation of Industry, Research, Suits and Litigation (Civil) 0 The agency’s accelerated approval program for certain drugs has come under intense scrutiny because some medicines stay on the market despite limited evidence that they work.